220 related articles for article (PubMed ID: 17957144)
1. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.
Park SM; Shell S; Radjabi AR; Schickel R; Feig C; Boyerinas B; Dinulescu DM; Lengyel E; Peter ME
Cell Cycle; 2007 Nov; 6(21):2585-90. PubMed ID: 17957144
[TBL] [Abstract][Full Text] [Related]
2. Let-7 expression defines two differentiation stages of cancer.
Shell S; Park SM; Radjabi AR; Schickel R; Kistner EO; Jewell DA; Feig C; Lengyel E; Peter ME
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11400-5. PubMed ID: 17600087
[TBL] [Abstract][Full Text] [Related]
3. [Construction of let-7d expression vector and its inhibitory effect on HMGA2 and ras expression in human ovarian cancer cells in vitro].
Ye H; Chen J; Huang X; Guo A; Hao P
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1752-7. PubMed ID: 23268403
[TBL] [Abstract][Full Text] [Related]
4. [Overexpression of high mobility group A2 and its correlation with microRNA let-7 family in serous ovarian cancers].
Yang J; Zhang Q; Dong JQ; Chang XH; He XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):749-54. PubMed ID: 23073586
[TBL] [Abstract][Full Text] [Related]
5. Regulation of HMGA2 and KRAS genes in epithelial ovarian cancer by miRNA hsa-let-7d-3p.
Gunel T; Dogan B; Gumusoglu E; Hosseini MK; Topuz S; Aydinli K
J Cancer Res Ther; 2019; 15(6):1321-1327. PubMed ID: 31898667
[TBL] [Abstract][Full Text] [Related]
6. The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family.
Busch B; Bley N; Müller S; Glaß M; Misiak D; Lederer M; Vetter M; Strauß HG; Thomssen C; Hüttelmaier S
Nucleic Acids Res; 2016 May; 44(8):3845-64. PubMed ID: 26917013
[TBL] [Abstract][Full Text] [Related]
7. Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression.
Agostini A; Brunetti M; Davidson B; Tropé CG; Heim S; Panagopoulos I; Micci F
Oncotarget; 2017 Mar; 8(13):21554-21560. PubMed ID: 28423547
[TBL] [Abstract][Full Text] [Related]
8. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.
Xing F; Song Z; He Y
Biol Res; 2018 Nov; 51(1):50. PubMed ID: 30474570
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma.
Peng Y; Laser J; Shi G; Mittal K; Melamed J; Lee P; Wei JJ
Mol Cancer Res; 2008 Apr; 6(4):663-73. PubMed ID: 18403645
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.
Motoyama K; Inoue H; Nakamura Y; Uetake H; Sugihara K; Mori M
Clin Cancer Res; 2008 Apr; 14(8):2334-40. PubMed ID: 18413822
[TBL] [Abstract][Full Text] [Related]
11. Let-7 repression leads to HMGA2 overexpression in uterine leiomyosarcoma.
Shi G; Perle MA; Mittal K; Chen H; Zou X; Narita M; Hernando E; Lee P; Wei JJ
J Cell Mol Med; 2009 Sep; 13(9B):3898-905. PubMed ID: 19602040
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression.
Wang YY; Ren T; Cai YY; He XY
Cancer Biother Radiopharm; 2013 Mar; 28(2):131-7. PubMed ID: 23134218
[TBL] [Abstract][Full Text] [Related]
13. Roles of microRNA let-7b in papillary thyroid carcinoma by regulating HMGA2.
Li H; Zhao L; Zhang Z; Zhang H; Ding C; Su Z
Tumour Biol; 2017 Oct; 39(10):1010428317719274. PubMed ID: 29025376
[TBL] [Abstract][Full Text] [Related]
14. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.
Lee YS; Dutta A
Genes Dev; 2007 May; 21(9):1025-30. PubMed ID: 17437991
[TBL] [Abstract][Full Text] [Related]
16. HMGA2 gene is a promising target for ovarian cancer silencing therapy.
Malek A; Bakhidze E; Noske A; Sers C; Aigner A; Schäfer R; Tchernitsa O
Int J Cancer; 2008 Jul; 123(2):348-356. PubMed ID: 18452175
[TBL] [Abstract][Full Text] [Related]
17. The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypes.
Eide HA; Halvorsen AR; Bjaanæs MM; Piri H; Holm R; Solberg S; Jørgensen L; Brustugun OT; Kiserud CE; Helland Å
BMC Cancer; 2016 Feb; 16():71. PubMed ID: 26858029
[TBL] [Abstract][Full Text] [Related]
18. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
[TBL] [Abstract][Full Text] [Related]
19. HMGA2 is down-regulated by microRNA let-7 and associated with epithelial-mesenchymal transition in oesophageal squamous cell carcinomas of Kazakhs.
Liu Q; Liu T; Zheng S; Gao X; Lu M; Sheyhidin I; Lu X
Histopathology; 2014 Sep; 65(3):408-17. PubMed ID: 24612219
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Localization Signal-Enhanced Polyurethane-Short Branch Polyethylenimine-Mediated Delivery of Let-7a Inhibited Cancer Stem-Like Properties by Targeting the 3'-UTR of HMGA2 in Anaplastic Astrocytoma.
Yang MY; Chen MT; Huang PI; Wang CY; Chang YC; Yang YP; Lo WL; Sung WH; Liao YW; Lee YY; Chang YL; Tseng LM; Chen YW; Ma HI
Cell Transplant; 2015; 24(8):1431-50. PubMed ID: 24898358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
